Nurse Practitioner, Acute Care · Gainesville, GA
NPI
1285631887
Since 2005
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
102 Barrett St
Gainesville, GA, 30501
Phone (770) 540-4274
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
611 services
Medicare patients, 2024
249
Average age 77
Drug cost, 2024
$3.1M
3,121 prescriptions
Company payments, 2025
$2,919
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Clark was code 99214 (office e&m - established), 426 times for 229 patients. In total Mark D Clark billed 611 services in 5 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 426 | 229 | $80.83 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 153 | 127 | $10.56 | $1,616 |
| 99213 Office E&M - Established | Office | 23 | 22 | $57.38 | $1,320 |
By year: 2022 $64K for 1,416 services; 2023 $21K for 522 services; 2024 $38K for 611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Clark prescribed most often to Medicare patients was Potassium Chloride, with 174 prescriptions and refills. In total Mark D Clark wrote 3,121 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Chloride Generic | 174 | 272 | 41 | $2,382 |
| Levothyroxine Sodium Generic | 155 | 250 | 27 | $858 |
| Anastrozole Generic | 150 | 308 | 34 | $2,715 |
| Eliquis Apixaban | 134 | 158 | 24 | $90K |
| Gabapentin Generic | 133 | 179 | 35 | $1,066 |
| Mirtazapine Generic | 93 | 121 | 26 | $1,926 |
| Ondansetron Hcl Generic | 91 | 104 | 52 | $3,611 |
| Xtandi Enzalutamide | 73 | 73 | Under 11 | $982K |
| Tamoxifen Citrate Generic | 72 | 122 | 16 | $1,271 |
| Acyclovir Generic | 69 | 123 | 15 | $1,309 |
| Xarelto Rivaroxaban | 68 | 102 | 12 | $59K |
| Trazodone Hcl Generic | 67 | 86 | 17 | $274 |
| Citalopram Hbr Citalopram Hydrobromide | 65 | 95 | 13 | $259 |
| Prednisone Generic | 64 | 108 | 20 | $428 |
| Pantoprazole Sodium Generic | 59 | 134 | 22 | $449 |
Brand drugs: - claims; generic drugs: 2,565 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Clark $2,919 ($2,919 in general payments such as food, travel and fees) from 32 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $932.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $932 |
| Daiichi Sankyo Inc. 4568.T | 4 | $164 |
| Janssen Biotech, Inc. JNJ | 9 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $140 |
| Merck Sharp & Dohme LLC MRK | 5 | $131 |
| Pfizer Inc. PFE | 6 | $125 |
| Abbvie Inc. ABBV | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $112 |
| Astellas Pharma US Inc 4503.T | 3 | $102 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $95.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.